Back

Watch Compare

Minerva Neurosciences, Inc.

Data quality: 83%

NERV

NASDAQ Manufacturing Chemicals

$5.87

▲ $0.17 (2.98%)

6 months return

—

Momentum

Neutral

1Y earnings growth

-20492.68%

Growth

Revenue Growth (5Y)

N/A

Revenue (1Y)N/A

Earnings (1Y)-20492.68%

FCF Growth (3Y)N/A

Quality

Return on Equity

N/A

ROIC-44.76%

Net MarginN/A

Op. MarginN/A

Safety

Debt / Equity

N/A

Current Ratio4.87

Interest CoverageN/A

Valuation

PE (TTM|NTM)

-0.82 | -11.48

Above sector avg (-1.50)

P/B RatioN/A

EV/EBITDAN/A

Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Earnings declined -20492.68% over the past year

Negative free cash flow of -13.51 M

Price History

Financial Trends

Analyst Price Target

2 analysts

Hold

+23.5%

upside to target

Current

$5.87

Consensus Target

$7.25

$7.00

Low

$7.50

High

Forecast

Forward P/E

-11.48

Forward EPS

-$0.48

Est. Revenue

0.0

Earnings Surprises

EPS

Reported Estimate Forecast

Next: Q1 2026 · EPS Est: -$0.13 · Rev Est: 0.0

	Q12025	Q22025	Q32025	Q42025	Q1 '26	Q2 '26
Reported	-$0.50	-$0.43	-$0.36	-$0.64	—	—
Estimate	-$1.07	-$0.90	—	-$0.11	-$0.13	-$0.18
Surprise	+53.27%	+52.22%	—	-481.82%	—	—

Growth

Rev 5Y: N/A · Earnings 1Y: -20492.68%

Revenue Growth (1Y)	N/A	Revenue Growth (3Y)	N/A
Earnings Growth (1Y)	-20492.68%	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	N/A	Earnings Growth (5Y)	N/A

Profitability

ROE: N/A · Net Margin: N/A

Revenue (TTM)	N/A	Net Income (TTM)	-293.42 M
ROE	N/A	ROA	-1002.96%
Gross Margin	N/A	Operating Margin	N/A
Net Margin	N/A	Free Cash Flow (TTM)	-13.51 M
ROIC	-44.76%	FCF Growth (3Y)	N/A

Safety

D/E: N/A · Current: 4.87

Debt / Equity	N/A	Current Ratio	4.87
Interest Coverage	N/A	Asset Turnover	N/A
Working Capital	10.35 M	Tangible Book Value	-49.45 M

Dividends

Yield: N/A · Payout: N/A

Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A

Valuation

P/E: -0.82 · EV/EBITDA: N/A

P/E Ratio	-0.82	Forward P/E	-11.48
P/B Ratio	N/A	P/S Ratio	N/A
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-5.63%
Market Cap	239.96 M	Enterprise Value	227.67 M

Per Share

EPS: -34.67 · FCF/Share: -0.31

EPS (Diluted TTM)	-34.67	Revenue / Share	N/A
FCF / Share	-0.31	OCF / Share	-0.31
EPS CAGR (1Y)	-18347.37%	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A

Efficiency

FCF Conv: 4.60% · CapEx/Rev: N/A

CapEx / Revenue	N/A	FCF Conversion	4.60%
SBC-Adj. FCF	-14.69 M	Growth Momentum	N/A

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	—	0.0	0.0	0.0	41.18 M
Net Income	-293.42 M	1.44 M	-30.01 M	-32.11 M	-49.91 M
EPS (Diluted)	-34.67	0.19	-4.61	-6.01	-1.17
Gross Profit	—	—	—	—	—
Operating Income	-15.10 M	-21.85 M	-23.12 M	-25.23 M	-45.37 M
EBITDA	—	—	—	—	—
R&D Expenses	5.76 M	11.90 M	12.71 M	14.65 M	32.04 M
SG&A Expenses	—	—	—	—	—
D&A	5,442.0	5,442.0	5,442.0	—	16,011.0
Interest Expense	—	—	—	—	—
Income Tax	—	—	—	-1.80 M	-1.80 M

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	97.97 M	37.14 M	56.90 M	55.09 M	77.12 M
Total Liabilities	233.76 M	62.84 M	85.36 M	75.11 M	69.15 M
Shareholders' Equity	-140.75 M	-25.69 M	-28.46 M	-20.02 M	7.98 M
Total Debt	—	—	—	—	—
Cash & Equivalents	82.30 M	21.36 M	40.91 M	36.09 M	60.76 M
Current Assets	83.10 M	22.27 M	42.00 M	40.16 M	62.20 M
Current Liabilities	2.29 M	2.84 M	3.34 M	1.38 M	2.82 M

Peer Comparison

vs Manufacturing sector median (1605 peers)

Metric	Stock	Sector Median
P/E	-0.8	-1.5
P/B	—	1.6
ROE %	—	-54.7
Net Margin %	—	-41.5
Rev Growth 5Y %	—	1.7
D/E	—	0.3